Dexcom (DXCM) Raw Materials (2010 - 2026)

Dexcom (DXCM) has 13 years of Raw Materials data on file, last reported at $247.9 million in Q1 2026.

• Quarterly Raw Materials fell 32.27% year-over-year to $247.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $247.9 million (down 32.27% YoY) and the FY2025 annual result came in at $257.6 million, down 21.25% from the prior year.
• Raw Materials eased to $247.9 million in Q1 2026 per DXCM's latest filing, from $257.6 million in the prior quarter.
• Across five years, Raw Materials topped out at $366.0 million in Q1 2025 and bottomed at $151.1 million in Q2 2022.
• The 5-year median for Raw Materials is $257.6 million (2025), against an average of $254.0 million.
• The widest annual swing landed in 2023, when Raw Materials jumped 100.94%; it then plunged 32.27% in 2026.
• Tracing DXCM's Raw Materials over 5 years: stood at $159.0 million in 2022, then jumped by 100.94% to $319.5 million in 2023, then increased by 2.38% to $327.1 million in 2024, then retreated by 21.25% to $257.6 million in 2025, then fell by 3.77% to $247.9 million in 2026.
• Per Business Quant, the three latest DXCM Raw Materials figures stand at $247.9 million (Q1 2026), $257.6 million (Q4 2025), and $266.0 million (Q3 2025).

Peer Comparison